Current and historical daily PE Ratio for Siemens Healthineers AG (
LTS:0PMJ
) from 2018 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Siemens Healthineers AG stock (LTS:0PMJ) PE ratio as of Jun 19 2024 is 31.59.
More Details
Siemens Healthineers AG (LTS:0PMJ) PE Ratio (TTM) Chart
Siemens Healthineers AG (LTS:0PMJ) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1298
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Siemens Healthineers AG PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 31.8 | 2024-04-16 | 32.2 |
2024-06-18 | 31.8 | 2024-04-15 | 32.8 |
2024-06-17 | 32.3 | 2024-04-12 | 32.6 |
2024-06-14 | 32.8 | 2024-04-11 | 33.1 |
2024-06-13 | 33.4 | 2024-04-10 | 33.5 |
2024-06-12 | 33.5 | 2024-04-09 | 33.3 |
2024-06-11 | 33.7 | 2024-04-08 | 33.8 |
2024-06-10 | 33.4 | 2024-04-05 | 33.5 |
2024-06-07 | 33.7 | 2024-04-04 | 33.7 |
2024-06-06 | 33.7 | 2024-04-03 | 34.2 |
2024-06-05 | 33.3 | 2024-04-02 | 34.1 |
2024-06-04 | 32.6 | 2024-04-01 | 34.6 |
2024-06-03 | 32.3 | 2024-03-29 | 34.6 |
2024-05-31 | 32.6 | 2024-03-28 | 34.6 |
2024-05-30 | 32.8 | 2024-03-27 | 41.6 |
2024-05-29 | 32.7 | 2024-03-26 | 40.9 |
2024-05-28 | 33.0 | 2024-03-25 | 40.9 |
2024-05-24 | 32.6 | 2024-03-22 | 40.9 |
2024-05-23 | 32.8 | 2024-03-21 | 40.8 |
2024-05-22 | 32.9 | 2024-03-20 | 41.1 |
2024-05-21 | 32.2 | 2024-03-19 | 41.2 |
2024-05-20 | 32.3 | 2024-03-18 | 41.2 |
2024-05-17 | 33.0 | 2024-03-15 | 41.7 |
2024-05-16 | 33.1 | 2024-03-14 | 41.8 |
2024-05-15 | 32.2 | 2024-03-13 | 41.5 |
2024-05-14 | 32.2 | 2024-03-12 | 42.4 |
2024-05-13 | 32.2 | 2024-03-11 | 42.4 |
2024-05-10 | 32.3 | 2024-03-08 | 42.9 |
2024-05-09 | 31.7 | 2024-03-07 | 42.5 |
2024-05-08 | 30.6 | 2024-03-06 | 42.1 |
2024-05-07 | 30.6 | 2024-03-05 | 41.8 |
2024-05-06 | 31.6 | 2024-03-04 | 41.7 |
2024-05-03 | 31.6 | 2024-03-01 | 41.0 |
2024-05-02 | 31.3 | 2024-02-29 | 40.9 |
2024-05-01 | 31.8 | 2024-02-28 | 41.0 |
2024-04-30 | 31.6 | 2024-02-27 | 41.1 |
2024-04-29 | 32.8 | 2024-02-26 | 40.4 |
2024-04-26 | 32.2 | 2024-02-23 | 40.5 |
2024-04-25 | 31.9 | 2024-02-22 | 40.2 |
2024-04-24 | 32.2 | 2024-02-21 | 39.4 |
2024-04-23 | 31.6 | 2024-02-20 | 40.6 |
2024-04-22 | 31.2 | 2024-02-19 | 40.7 |
2024-04-19 | 30.9 | 2024-02-16 | 40.6 |
2024-04-18 | 31.4 | 2024-02-15 | 40.2 |
2024-04-17 | 31.9 | 2024-02-14 | 39.8 |
Siemens Healthineers AG (LTS:0PMJ) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Siemens Healthineers AG Siemens Healthineers AG logo](https://static.gurufocus.com/logos/0C0000BER6.png?14)
Siemens Healthineers AG
ISIN : DE000SHL1006
Share Class Description:
LTS:0PMJ: Registered SharesCompare
Compare
Traded in other countries / regions
0PMJ.UKSHL.GermanySMMNY.USASHL.Austria1SHL.ItalySHL.SwitzerlandSHL.Mexico IPO Date
2018-07-18Description
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.